MML Investors Services
ABBV icon

MML Investors Services’s AbbVie ABBV Stock Holding History

MML Investors Services’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$120M Sell
551,567
-107,956
-16% -$23.9M 0.33% 63
2025
Q4 		$151M Buy
659,523
+28,130
+4% +$6.41M 0.37% 60
2025
Q3 		$146M Sell
631,393
-4,247
-0.7% -$865K 0.39% 51
2025
Q2 		$118M Buy
635,640
+28,710
+5% +$5.34M 0.34% 56
2025
Q1 		$127M Buy
606,930
+5,890
+1% +$1.15M 0.42% 40
2024
Q4 		$107M Buy
601,040
+52,379
+10% +$9.63M 0.37% 52
2024
Q3 		$108M Buy
548,661
+11,580
+2% +$2.16M 0.39% 46
2024
Q2 		$92.1M Sell
537,081
-20,173
-4% -$3.34M 0.37% 46
2024
Q1 		$101M Buy
557,254
+3,463
+0.6% +$597K 0.42% 41
2023
Q4 		$85.8M Buy
553,791
+72,822
+15% +$10.6M 0.4% 45
2023
Q3 		$71.7M Buy
480,969
+7,866
+2% +$1.15M 0.4% 48
2023
Q2 		$63.7M Buy
473,103
+40,882
+9% +$6M 0.35% 50
2023
Q1 		$68.9M Sell
432,221
-37,326
-8% -$5.71M 0.49% 35
2022
Q4 		$75.9M Buy
469,547
+29,350
+7% +$4.5M 0.5% 31
2022
Q3 		$59.1M Buy
440,197
+42,753
+11% +$6.14M 0.45% 37
2022
Q2 		$60.9M Buy
397,444
+39,978
+11% +$6.11M 0.46% 35
2022
Q1 		$57.9M Buy
357,466
+8,053
+2% +$1.17M 0.41% 41
2021
Q4 		$47.3M Buy
349,413
+6,319
+2% +$746K 0.34% 52
2021
Q3 		$37M Buy
343,094
+21,280
+7% +$2.43M 0.29% 63
2021
Q2 		$36.2M Buy
321,814
+12,501
+4% +$1.41M 0.3% 58
2021
Q1 		$33.5M Buy
309,313
+5,121
+2% +$548K 0.32% 57
2020
Q4 		$32.6M Buy
304,192
+30,609
+11% +$2.94M 0.35% 59
2020
Q3 		$24M Buy
273,583
+8,968
+3% +$844K 0.3% 71
2020
Q2 		$26M Buy
264,615
+33,648
+15% +$2.96M 0.35% 67
2020
Q1 		$17.6M Buy
230,967
+22,127
+11% +$1.88M 0.3% 76
2019
Q4 		$18.5M Buy
208,840
+28,961
+16% +$2.4M 0.26% 91
2019
Q3 		$13.6M Sell
179,879
-49,356
-22% -$3.38M 0.22% 121
2019
Q2 		$16.7M Buy
229,235
+22,908
+11% +$1.8M 0.24% 109
2019
Q1 		$16.6M Buy
206,327
+29,860
+17% +$2.44M 0.26% 101
2018
Q4 		$16.3M Buy
176,467
+22,377
+15% +$1.97M 0.29% 90
2018
Q3 		$14.6M Buy
154,090
+41,136
+36% +$3.9M 0.25% 102
2018
Q2 		$10.5M Buy
112,954
+5,480
+5% +$535K 0.23% 111
2018
Q1 		$10.2M Sell
107,474
-5,426
-5% -$596K 0.22% 115
2017
Q4 		$10.9M Sell
112,900
-13,404
-11% -$1.26M 0.21% 110
2017
Q3 		$11.2M Sell
126,304
-24,328
-16% -$1.85M 0.23% 101
2017
Q2 		$10.9M Buy
150,632
+13,241
+10% +$890K 0.21% 106
2017
Q1 		$8.95M Buy
137,391
+133,049
+3,064% +$8.36M 0.18% 56
2016
Q4 		$272K Buy
+4,342
New +$265K 0.3% 37

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MML Investors Services's ABBV Position: Q1 2026 in Review

MML Investors Services reduced its AbbVie (ABBV) stake by 16% in Q1 2026, selling an estimated $23.9M and leaving 551,567 shares worth $120M. The position accounts for 0.33% of the portfolio, ranked #63.

MML Investors Services first reported a position in ABBV in Q4 2016 and has held it in 38 quarters since. The position peaked at $151M in Q4 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • MML Investors Services held 551,567 shares of AbbVie worth $120M as of Q1 2026.
  • MML Investors Services sold 107,956 AbbVie shares in Q1 2026, an estimated $23.9M.
  • AbbVie made up 0.33% of MML Investors Services's portfolio in Q1 2026, its #63 holding.
  • MML Investors Services first reported a position in AbbVie in Q4 2016 and has held it in 38 quarters since.
  • MML Investors Services's AbbVie position peaked at $151M in Q4 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on MML Investors Services's 13F filing for Q1 2026, filed 4 May 2026.